Ocugen (OCGN) Current Leases (2018 - 2026)
Ocugen (OCGN) posted Current Leases of $850000.0 for Q1 2026, down 0.93% on a QoQ basis from $858000.0 in Q4 2025, and up 15.49% year-over-year from $736000.0 in Q1 2025.
Ocugen (OCGN) Current Leases (2018 - 2026) Analysis & Trends
Ocugen's Current Leases history runs 9 years deep, the most recent figure standing at $850000.0 for Q1 2026.
- Quarterly Current Leases rose 15.49% year-over-year to $850000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $850000.0 (up 15.49% YoY) and the FY2025 annual result came in at $858000.0, up 65.32% from the prior year.
- Current Leases was $850000.0 for Q1 2026 at Ocugen, down from $858000.0 in the prior quarter.
- Across five years, Current Leases topped out at $858000.0 in Q4 2025 and bottomed at $254000.0 in Q1 2022.
- A 5-year average of $579941.2 and a median of $526000.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases soared 157.56% — and 2024, when it slipped 12.36%.
- Ocugen's Current Leases stood at $498000.0 in 2022, then increased by 15.26% to $574000.0 in 2023, then fell by 9.58% to $519000.0 in 2024, then surged by 65.32% to $858000.0 in 2025, then dropped by 0.93% to $850000.0 in 2026.
- Business Quant data shows OCGN's Current Leases at $850000.0 in Q1 2026, $858000.0 in Q4 2025, and $855000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 850,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 850,000.00 |
| Dec 31, 2025 | 858,000.00 |
| Sep 30, 2025 | 855,000.00 |
| Jun 30, 2025 | 853,000.00 |
| Mar 31, 2025 | 736,000.00 |
| Dec 31, 2024 | 519,000.00 |
| Sep 30, 2024 | 477,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Dec 31, 2023 | 574,000.00 |
| Sep 30, 2023 | 540,000.00 |
| Jun 30, 2023 | 526,000.00 |
| Mar 31, 2023 | 512,000.00 |
| Dec 31, 2022 | 498,000.00 |
| Sep 30, 2022 | 443,000.00 |
| Jun 30, 2022 | 314,000.00 |
| Mar 31, 2022 | 254,000.00 |
| Dec 31, 2021 | 363,000.00 |
| Sep 30, 2021 | 172,000.00 |
| Jun 30, 2021 | 168,000.00 |